692 results
Page 9 of 35
6-K
EX-99.1
98wm2srbn9ibalqn9ug
30 Sep 13
Live Filing
12:00am
6-K
qwbxv1tj
30 Sep 13
Live Filing
12:00am
6-K
EX-99.1
o4fvf 19412eult50u43
26 Sep 13
Live Filing
12:00am
6-K
EX-99.1
wzq0kcd65svg03 41n
24 Sep 13
Teva Announces Exclusive Launch of Generic Adenoscan® In the United States
12:00am
6-K
EX-99.1
3dscd1l ykgr9bna
23 Sep 13
Teva Announces Favorable Court Ruling In Azilect® Patent Infringement Litigation Against Mylan
12:00am
6-K
EX-99.1
pia218 7ph
20 Sep 13
Teva Announces Exclusive Launch of Generic Niaspan® In the United States
12:00am
6-K
EX-99.1
k91jgjwhv5pb00wg
17 Sep 13
Fda Approves Teva’s Treanda® (Bendamustine Hci) Injection, a New Liquid Formulation
12:00am
6-K
tk0gasly
16 Sep 13
Live Filing
12:00am
6-K
EX-99.1
tmqovky
16 Sep 13
Live Filing
12:00am
6-K
EX-99.1
34dv9o2nyfl92vegzpd6
30 Aug 13
Live Filing
12:00am
6-K
EX-99
y3zad084gmb2dtnd
12 Aug 13
Teva Pharmaceuticals and Perrigo Company Announce the U.s. Launch of Generic Temozolomide
12:00am
6-K
EX-99.1
8kmn8ao85
8 Aug 13
Live Filing
12:00am
6-K
EX-99.1
ar2gm0 ug8akqou
1 Aug 13
Teva Reports Second Quarter 2013 Results
12:00am
6-K
EX-99.1
b3jm1
29 Jul 13
English Court of Appeal finds in favor of Teva on Copaxone® patent litigation and upholds validity of Copaxone patent until May 2015
12:00am
6-K
EX-99.1
pltcju rn1m
29 Jul 13
Live Filing
12:00am
6-K
EX-99.1
q80tekiob2ig
26 Jul 13
Teva Provides Update on COPAXONE® Litigation
12:00am
6-K
EX-99.1
j0x19tcj5b3b11 7dj6
25 Jul 13
Teva and Lonza Announce Mutual Decision to Discontinue Biologics Joint Venture
12:00am
6-K
EX-99.1
k2x91o
23 Jul 13
Live Filing
12:00am
6-K
ca0re zh5y84
18 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
calync9t1x
1 Jul 13
Live Filing
12:00am